These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6729621)

  • 1. Biochemical evidence for clinically diagnosed adrenoleucodystrophy in two brothers.
    Pretorius PJ; Reinecke CJ; Op't Hof J
    S Afr Med J; 1984 May; 65(21):860-2. PubMed ID: 6729621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: II. Lipid biochemical studies.
    Taketomi T; Hara A; Kitazawa N; Takada K; Nakamura H
    Jpn J Exp Med; 1987 Feb; 57(1):59-70. PubMed ID: 3476777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial adrenoleukodystrophy].
    Le Fur JM; Le Meur F; Parent P; Toudic L; Castel Y
    J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP; Moser HW; Saxena KM; Marmion LC
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
    Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy: clinical, pathological and biochemical findings in two brothers with the onset of cerebral disease in adult life.
    Esiri MM; Hyman NM; Horton WL; Lindenbaum RH
    Neuropathol Appl Neurobiol; 1984; 10(6):429-45. PubMed ID: 6527732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
    Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
    J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoleukodystrophy: from bedside to molecular biology.
    Moser HW
    J Child Neurol; 1987 Apr; 2(2):140-50. PubMed ID: 3598142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance tomography of adrenoleukodystrophy].
    Henkes H; Sperner J; Sander B
    Rontgenblatter; 1990 Jan; 43(1):7-10. PubMed ID: 2315642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenoleukodystrophy in a pair of siblings].
    Rosskamp R; Fichsel H; Röder B; Conzelmann E; Hinrichs U
    Klin Padiatr; 1985; 197(1):61-4. PubMed ID: 2983146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
    Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
    Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of female carriers of adrenoleukodystrophy.
    Moser HW; Moser AE; Trojak JE; Supplee SW
    J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts.
    Rizzo WB; Avigan J; Chemke J; Schulman JD
    Neurology; 1984 Feb; 34(2):163-9. PubMed ID: 6538003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
    Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
    J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
    Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
    J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.